Vanishing white matter disease in a child presenting with ataxia

C J Wilson1, J C Pronk, M S Van der Knaap

  • 1National Metabolic Service, Starship Hospital, Auckland, New Zealand. callumw@adhb.govt.nz

Insights

Vanishing white matter disease, a neurological disorder, involves episodic deterioration often triggered by fever or trauma. This study reports the first confirmed Australasian patient with this rare leukoencephalopathy.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Vanishing white matter disease (VWMD) is a rare, inherited leukoencephalopathy.
  • Characterized by chronic and episodic neurological deterioration, often presenting in childhood with ataxia and tremor.
  • Caused by mutations in EIF2B1-5 genes, affecting translation initiation factor eIF2B.

Observation:

  • Episodic neurological decline frequently follows fever or minor head trauma.
  • Brain MRI reveals extensive cerebral white matter abnormalities, including rarefaction and cystic degeneration.
  • Pathological examination confirms white matter abnormalities.

Findings:

  • Mutations in any of the five EIF2B genes can cause VWMD.
  • The underlying defect in eIF2B leads to dysregulation of protein synthesis.
  • This is the first confirmed case of VWMD reported in the Australasian region.

Implications:

  • Highlights the genetic basis and biochemical pathways involved in VWMD.
  • Emphasizes the importance of early diagnosis and genetic counseling for affected families.
  • Contributes to the understanding of leukoencephalopathies and their impact on neurological function.